Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide

Methionine Uptake and Required Radiation Dose to Control Glioblastoma

(2015) Toshihiko Iuchi et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

(2014) Toshihiko Iuchi et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis

(2014) Shingo Yonezawa et al.   JOURNAL OF NEURO-ONCOLOGY

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

(2014) Mark R. Gilbert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab Treatment for Symptomatic Radiation Necrosis Diagnosed by Amino Acid PET

(2013) M. Furuse et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature

(2013) Daniel Lubelski et al.   JOURNAL OF NEURO-ONCOLOGY

Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy

(2012) M Matsuda et al.   BRITISH JOURNAL OF RADIOLOGY

Impact of [11C]Methionine Positron Emission Tomography for Target Definition of Glioblastoma Multiforme in Radiation Therapy Planning

(2010) Masayuki Matsuo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase I/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme

(2009) Masashi Mizumoto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS